Skip to main content
Clinical Trials/CTRI/2019/01/016901
CTRI/2019/01/016901
Not yet recruiting
未知

Short term outcome in patients receiving Neoadjuvant Chemotherapy followed by surgery and those undergoing surgery alone in Locally advanced Carcinoma Stomach

JIPMER0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: C169- Malignant neoplasm of stomach, unspecified
Sponsor
JIPMER
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
JIPMER

Eligibility Criteria

Inclusion Criteria

  • Patients attending surgery clinics with TNM stage T3, T4, any N, M0 histologically proven adenocarcinoma stomach by UGI endoscopy guided biopsy and Contrast enhanced CT scan(CECT) will be included in the study

Exclusion Criteria

  • Patients with any other coexisting malignancies, age 70 and above, those who are already on chemotherapy, and patients with recurrence will be not included in the study. Tumors localized to Gastroesophageal junction (Type I) will be excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials